News - Page 10 of 40

“A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients.”

Bustos, M. A., R. Gross, N. Rahimzadeh, H. Cole, L. T. Tran, K. D. Tran, L. Takeshima, S. L. Stern, S. O'Day and D. S. B. Hoon
Cancers (Basel), 2020.

“Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis.”

Bustos, M. A., K. D. Tran, N. Rahimzadeh, R. Gross, S. Y. Lin, Y. Shoji, T. Murakami, C. L. Boley, L. T. Tran, H. Cole, D. F. Kelly, S. O'Day and D. S. B. Hoon
Cancers (Basel), 2020.

“Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma.”

Das, I., H. Chen, G. Maddalo, R. Tuominen, V. W. Rebecca, M. Herlyn, J. Hansson, M. A. Davies and S. Egyhazi Brage
Cell Death Dis, 2020.

“Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.”

Dellac, S., H. Ben-Dov, A. Raanan, H. Saleem, R. Zamostiano, R. Semyatich, S. Lavi, I. P. Witz, E. Bacharach and M. Ehrlich
Int J Cancer, 2020.

“Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.”

Fischer, G. M., F. C. L. Carapeto, A. Y. Joon, L. E. Haydu, H. Chen, F. Wang, J. S. Van Arnam, J. L. McQuade, K. Wani, J. M. Kirkwood, J. F. Thompson, M. T. Tetzlaff, A. J. Lazar, H. A. Tawbi, J. E. Gershenwald, R. A. Scolyer, G. V. Long and M. A. Davies
Cancer Med, 2020.

“Ataxia-Telangiectasia (A-T): An Emerging Dimension of Premature Ageing.”

Shiloh, Y. and H. M. Lederman
Ageing Res Rev, 2016.

“Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.”

Tal, P., S. Eizenberger, E. Cohen, N. Goldfinger, S. Pietrokovski, M. Oren and V. Rotter
Oncotarget, 2016.

“RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer.”

Tarcic, O., I. S. Pateras, T. Cooks, E. Shema, J. Kanterman, H. Ashkenazi, H. Boocholez, A. Hubert, R. Rotkopf, M. Baniyash, E. Pikarsky, V. G. Gorgoulis and M. Oren
Cell Rep, 2016.

“Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.”

Yoo, Y. D., D. H. Lee, H. Cha-Molstad, H. Kim, S. R. Mun, C. Ji, S. H. Park, K. S. Sung, S. A. Choi, J. Hwang, D. M. Park, S. K. Kim, K. J. Park, S. H. Kang, S. C. Oh, A. Ciechanover, Y. J. Lee, B. Y. Kim and Y. T. Kwon
EMBO Rep, 2016.

“On the linkage between the ubiquitin-proteasome system and the mitochondria.”

Lehmann, G., R. G. Udasin and A. Ciechanover
Biochem Biophys Res Commun, 2016.

“Ubiquitination of specific mitochondrial matrix proteins.”

Lehmann, G., T. Ziv, O. Braten, A. Admon, R. G. Udasin and A. Ciechanover
Biochem Biophys Res Commun, 2016.

“The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death.”

Livneh, I., V. Cohen-Kaplan, C. Cohen-Rosenzweig, N. Avni and A. Ciechanover
Cell Res, 2016.

“Hepatocellular carcinoma.”

Llovet, J. M., J. Zucman-Rossi, E. Pikarsky, B. Sangro, M. Schwartz, M. Sherman and G. Gores
Nat Rev Dis Primers, 2016.

“Adaptive preconditioning in neurological diseases – Therapeutic insights from proteostatic perturbations.”

Mollereau, B., N. M. Rzechorzek, B. D. Roussel, M. Sedru, D. Van den Brink, B. Bailly-Maitre, F. Palladino, D. B. Medinas, P. M. Domingos, S. Hunot, S. Chandran, S. Birman, T. Baron, D. Vivien, C. B. Duarte, H. D. Ryoo, H. Steller, F. Urano, E. Chevet, G. Kroemer, A. Ciechanover, E. J. Calabrese, R. J. Kaufman and C. Hetz
Brain Res, 2016.

“Focal and Local: Ectopic Lymphoid Structures and Aggregates of Myeloid and Other Immune Cells in Liver.”

Pikarsky, E. and M. Heikenwalder
Gastroenterology, 2016.

“Systemic DNA damage responses in aging and diseases.”

Ribezzo, F., Y. Shiloh and B. Schumacher
Semin Cancer Biol, 2016.